Key Highlights
•
A new blood test for Alzheimer’s disease, which measures a specific protein called p-tau217, has been validated for clinical use with high accuracy. This provides a simpler and less invasive alternative to spinal taps or brain scans for detecting Alzheimer’s pathology.
Source →
•
A large study in New Zealand found that repeated vitamin D testing is very common, but most repeat tests show normal levels, suggesting the tests are often unnecessary. Restricting unnecessary repeat testing could save significant healthcare resources without missing many cases of true deficiency.
Source →
•
In women with both cervical cancer and HIV, a simple blood test result called a high neutrophil-to-lymphocyte ratio (NLR) strongly predicts worse survival outcomes. This easy-to-measure marker could help doctors identify patients who may need more aggressive treatment or closer monitoring.
Source →
•
An editorial highlights a major ethical concern: many pediatric hospice programs in the US require families to sign a “Do Not Resuscitate” order before enrolling their child. This policy creates a barrier to compassionate end-of-life care and conflicts with the goal of honoring family values during an incredibly difficult time.
Source →
•
A clinical trial is investigating whether adding the antibiotic tobramycin to the standard vancomycin regimen before surgery reduces serious infections in patients with complex leg fractures. Finding the most effective antibiotic combination is crucial for preventing complications in high-risk surgeries.
Source →
•
Researchers have identified a specific receptor in the body, called GPR84, that drives the harmful inflammation seen in Buruli ulcer, a neglected tropical skin disease. This discovery opens the door for developing new drugs that target this receptor to treat the condition more effectively.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
